US00449L1026 - ADR
ACHILLES THERAPEUTICS PL-ADR
NASDAQ:ACHL (4/24/2024, 4:47:57 PM)
After market: 0.785 +0 (+0.15%)0.7838
+0 (+0.35%)
Achilles Therapeutics Plc is a biopharmaceutical company engages in developing transformative precision T-cell therapies to treat multiple types of solid tumors. The firm develops transformative precision T cell therapies to treat multiple types of solid tumors. Its lead product is a precision tumor-derived T cell therapy targeting clonal cancer neoantigens. Its pipeline includes Chiron: Advanced Non-Small Cell Lung Cancer, Thetis: Melanoma (Monotherapy), Thetis: Melanoma (PD-1 Combination), and other indications. The company is focused on advancing cancer therapies through its work in the field of tumor evolution. Its platform enables to identify mutations formed early in the development of a cancer that give rise to antigens that are expressed by all of a patient's cancer cells but are absent from healthy tissue. The company refers to this class of solid tumor targets as clonal neoantigens. To identify clonal neoantigens in a patient, it has developed a bioinformatic platform called PELEUS.
ACHILLES THERAPEUTICS PL-ADR
245 Hammersmith Road, Gunnels Wood Road
London W6 8PW
P: 442081544600
CEO: Iraj Ali
Employees: 234
Website: https://www.achillestx.com/
What's going on in today's session
Wondering how the US markets performed in the middle of the day on Thursday? Discover the movers and shakers of today's session in our comprehensive analysis.
ACHL stock results show that Achilles Therapeutics missed analyst estimates for earnings per share the fourth quarter of 2023.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Achilles Therapeutics (NASDAQ:ACHL) just reported results for the fourth quarte...
The session on Thursday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.
Before the US market kicks off on Thursday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.
Here you can normally see the latest stock twits on ACHL, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: